newsfilter
← Latest News
PR Newswire·

Kuehn Law Encourages Investors of Aardvark Therapeutics, Inc. to Contact Law Firm

  • Kuehn Law, PLLC is investigating whether Aardvark Therapeutics officers & directors breached fiduciary duties.
  • The firm alleges the company misrepresented ARD-101 safety, IPO documents contained misleading statements, & overstated clinical prospects.
  • Shareholders who purchased AARD prior to March 1, 2025, are encouraged to contact attorney Sophia Anne Silayan.
  • Kuehn Law covers all case costs & charges no fees to investor clients.
  • The firm warns that there may be limited time to enforce shareholder rights.
  • Contact details include email [email protected] & phone number (833) 672-0814.